nSTRIDE APS in Females With Primary Patellofemoral Osteoarthritis

Status Completed

Clinical Trial Summary

The purpose of this study is to evaluate clinical outcomes following a single injection of nSTRIDE Autologous Protein Solution in females with isolated patellofemoral osteoarthritis. A secondary objective of this study is to document the duration of treatment effect following nSTRIDE injection.

Clinical Trial Description

Clinical trials have, in general, formally demonstrated the effectiveness and safety of various autologous therapies for the treatment of knee OA. Differences in the processing of autologous therapies can yield substantial differences in the resulting output. Thus, making generalizations regarding the effectiveness across these autologous therapies is more complicated. Each autologous therapy requires independent efficacy evaluation. nSTRIDE APS has been shown to decrease pain, increase function and have a favorable safety profile in a pilot trial. Further, demonstration of the treatment effects in patellofemoral osteoarthritis, an important subset of knee osteoarthritis is lacking. This study will evaluate a population of female patients with patellofemoral osteoarthritis in which treatment with other modalities provides limited/short lived relief with the hope that APS treatment will provide and extend relief to these patients. The study will document the treatment effects and timeline of treatment effects for nSTRIDE APS following a single injection (per symptomatic knee). ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02610192
Study type	Interventional
Source	Zimmer Biomet
Contact
Status	Completed
Phase	N/A
Start date	March 2016
Completion date	June 2018

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT06060730` - Measurement Properties of the Turkish Version of the Patellofemoral Pain and Osteoarthritis Subscale of the KOOS
Recruiting	`NCT04937998` - PRP Versus HA IN OSTEOARTHRITIS OF THE PATELLOFEMORAL JOINT	N/A
Completed	`NCT02825238` - Effect of Hip and Core Muscle Strengthening for Patellofemoral Osteoarthritis: A Feasibility Study	N/A
Completed	`NCT03281837` - 2 Weekly Intra-articular Hyaluronan Knee Injections, Given 1 wk. Apart, of HYMOVIS Combined With Physical Exercise Program (PEP) Compared to PEP Alone, in Relatively Young, Active Population of Subjects With Patellofemoral Osteoarthritis (PFOA) and/or Tibiofemoral Osteoarthritis (TFOA)	N/A
Completed	`NCT05184439` - Evaluation of Adductor Magnus Tenodesis in Patients With Recurrent Patellar Dislocation.
Not yet recruiting	`NCT04332900` - Proximal and Distal Therapeutic Approach in Pain and Lower Limb Kinematic in People With Patellofemoral Osteoarthritis	N/A
Recruiting	`NCT06163573` - Treatment of Patellofemoral Osteoarthritis With Engineered Cartilage.	Phase 2
Completed	`NCT04589871` - Taping Technique With Supervised Exercises Protocol on Pain and Functional Status in Individuals With Arthritis	N/A
Active, not recruiting	`NCT04817969` - Persona Ti-Nidium Post-Market Clinical Follow-up	N/A
Active, not recruiting	`NCT04772625` - Failure Analysis of Patellofemoral Arthroplasty
Terminated	`NCT00816647` - A Prospective Randomized Study of Medial Patellofemoral Ligament (MPFL) Reconstruction	N/A